HYBRID EVENT: You can participate in person at Madrid, Spain or Virtually from your home or work.

5th Edition of Cardiology World Conference

September 5-7, 2024 | Madrid, Spain

September 05 -07, 2024 | Madrid, Spain
Cardio 2024

Complementing echocardiography: diagnosing heart failure and valve disease on patient presentation at point of care

Marc Bisnaire, Speaker at Cardiology Conferences
Cardio-Phoenix Ltd, United Kingdom
Title : Complementing echocardiography: diagnosing heart failure and valve disease on patient presentation at point of care


Cardio-HART™ represents a revolutionary advancement in cardiac diagnostics, offering an AI-enabled point-of-care system capable of swiftly diagnosing prevalent cardiac conditions such as heart failure (HF) and valvular heart diseases (VHD) on the very day a patient presents. By seamlessly integrating the diagnostic capabilities of three key cardiac devices—12-Lead ECG, Phonocardiography (auscultation), and Echocardiography—it facilitates early detection and severity assessment of heart diseases right at the point-of-care.

The implementation of Cardio-HART in primary care yields two clinically validated benefits that directly impact diagnosis timelines: it either circumvents the need for secondary care or expedites it as necessary. Firstly, it curtails unnecessary echocardiograms in secondary care, optimizing resource allocation. Secondly, it significantly reduces false negatives, identifying primary care patients exhibiting heart failure symptoms likely to manifest in the Emergency Department imminently if overlooked.

Crucially, Cardio-HART provides findings on Left Ventricular Ejection Fraction (LVEF) alongside structural and functional cardiac abnormalities akin to echocardiography results, vital for comprehending their impact on cardiac health, particularly in cases of dyspnea where ECG alone falls short. Moreover, as a CE certified AI-enabled 12-Lead ECG device, Cardio-HART serves as a direct substitute for standard 12-Lead ECG devices in primary care settings. Quick, non-invasive, and yielding immediate results, it necessitates no specialists for intervention or result interpretation, easily operated by ECG-trained medical assistants with minimal training.

Addressing a wide array of healthcare needs spanning primary care through to tertiary care, virtual wards, and home care, Cardio-HART embodies a transformative leap forward in cardiac diagnostics, that complements Echocardiography.

Audience Take Away:

  • How diagnosing heart failure and Valve diseases on patient presentation means more immediate access to treatment for patients
  • See how Unnecessary Echocardiogram can be drastically reduced in secondary care
  • See how diagnosing preserved heart failure in primary care, on patient presentation will avoid the same patient presenting to the emergency department 6 months later. This addresses a serious problem for women over 60
  • Reduce wait time and backlogs for echocardiography, reserving appointments for patients that truly need one and need access to the cardiologist
  • Give primary care physicians more control over their patients, and provide them with answers they need sooner
  • Give patients more immediate access to treatments, avoiding disease progression and ending up in the emergency department because their condition was missed in primary care… for lack of a suitable device
  • Reduce secondary care costs, by hundreds of millions annually


Marc Bisnaire, with over two decades of expertise in technology, particularly in AI and advanced cardiac sensor technologies, he has spearheaded numerous clinical studies across Europe for the past decade. Prior to this, he founded and led a high-tech company to a successful exit, followed by a notable stint as VP of Innovation at a major American technology firm. Since then, he has dedicated his efforts to advancing this technology, collaborating closely with cardiologists across North America and Europe.